Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements ; volume:7 ; number:1 ; day:9 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Communications biology ; 7, Heft 1 (9.10.2024), 1-10, 12.2024
- Urheber
-
Raimondi, Federica
Siow, Kah Mun
Wrona, Dominik
Fuster García, Carla
Pastukhov, Oleksandr
Schmitz, Michael
Bargsten, Katja
Kissling, Lucas
Swarts, Daan C.
Geoffroy, Andrieux
Cathomen, Anton
Modlich, Ute
Jínek, Martin
Siler, Ulrich
Reichenbach, Janine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-024-06959-z
- URN
-
urn:nbn:de:101:1-2412262120079.140009092914
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raimondi, Federica
- Siow, Kah Mun
- Wrona, Dominik
- Fuster García, Carla
- Pastukhov, Oleksandr
- Schmitz, Michael
- Bargsten, Katja
- Kissling, Lucas
- Swarts, Daan C.
- Geoffroy, Andrieux
- Cathomen, Anton
- Modlich, Ute
- Jínek, Martin
- Siler, Ulrich
- Reichenbach, Janine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Natural history of Pearson syndrome
Pre-clinical development of HIV resistant genome edited human CD4+ T cells
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Natural history of Pearson syndrome
Pre-clinical development of HIV resistant genome edited human CD4+ T cells
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Natural history of Pearson syndrome